A Pilot Study of Piperacillin and Ciprofloxacin as Initial Therapy for Fever in Severely Neutropenic Leukemia Patients

References

• Schimpff S C, Satterlee W, Young V M, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061–1065
   PubMed Web of Science ®Google Scholar
• Pizzo P A. Empiric therapy and prevention of infection in the immunocompromised host. Principles and practice of infectious diseases, 2nd ed., G L Mandell, R G Douglas, Jr, J E Bennett. John Wiley, New York 1985; 1680–1688
   Google Scholar
• Winston D J, Ho W G, Young L S, Hewitt W L, Gale R P. Piperacillin plus amikacin therapy v. carbenicillin plus amikacin in febrile, granulocytopenic patients. Arch Intern Med 1982; 142: 1663–1667
   PubMed Web of Science ®Google Scholar
• Menichetti F, Del Favero A, Guerciolini R, Tonato M, Aversa F, Roila F, Frongillo R F, Martelli M F, Davis S, Pauluzzi S. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole. Infection 1986; 14: 261–267
   PubMed Web of Science ®Google Scholar
• Sage R, Hann I, Grant Prentice H, Deveraux S, Corringham R, Hoffbrand A V, Blacklock H, Stirling L, Guimares M, Trikka E, Bhamra A, Warner P, Noone P. A randomized trial of empirical antibiotic therapy with one of four β-lactam antibiotics in combination with netilmicin in febrile neutropenic patients. J Antimicrob Chemother 1988; 22: 237–247
   PubMed Web of Science ®Google Scholar
• Kelsey S M, Wood M E, Shaw E, Jenkins G C, Newland A C. A comparative study of intravenous ciprofloxacin and bensylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients. J Antimicrob Chemother 1990; 25: 149–157
   PubMed Web of Science ®Google Scholar
• Novakova I, Donelly P, de Pauw B. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia. Scand J Infect Dis 1990; 22: 705–711
   PubMed Web of Science ®Google Scholar
• Reeves D S, Bywater M I, Holt H A, White L O. In vitro studies with ciprofloxacin, a new 4-quinolone compound. J Antimicrob Chemother 1984; 13: 333–346
   PubMed Web of Science ®Google Scholar
• Chin N X, Jules K, Neu H C. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. Eur J Clin Microbiol 1986; 5: 23–28
   PubMedGoogle Scholar
• Chow A W, Wong J, Bartlett K H. Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrob Agents Chemother 1988; 32: 782–784
   PubMed Web of Science ®Google Scholar
• Forsgren A. Overview of Scandinavian in vitro studies with ciprofloxacin. Scand J Infect Dis 1989, Suppl 60: 16–22
   Google Scholar
• Bayston K F, Want S, Cohen J. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. Am J Med 1989, Suppl 5A: 269S–273S
   Google Scholar
• Johnson P RE, Liu Yin J A, Tooth J A. High dose intravenous ciprofloxacin in febrile neutropenic patients. J Antimicrob Chemother 1990; 26(Suppl F)101–107
   PubMed Web of Science ®Google Scholar
• From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis 1990; 161: 397–401
   PubMed Web of Science ®Google Scholar
• Meunier F, Zinner S H, Gaya H, Calandra T, Viscoli C, Klastersky J, Glauser M, The European Organization For Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. Antimicrob Agents Chemother 1991; 35: 873–878
   PubMed Web of Science ®Google Scholar
• Wade J C, Schimpff S C, Newman K A, Wiernick P H. Staphylococcus epidermidis; an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503–508
   PubMed Web of Science ®Google Scholar
• Samuelsson J, Lönnqvist B, Palmblad J, Grimfors G, Järnmark M, Lerner R, Ljungman P, Nyström-Rosander C, Öberg G. Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Scand J Infect Dis 1992; 24: 89–96
   PubMed Web of Science ®Google Scholar
• Kljucar S, Heimesaat M, von Pritzbuer E, Timm J, Scholl H, Beermann D. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections. Am J Med 1989, Suppl 5A: 52S–56S
   Google Scholar
• Yuen G J, Drusano G L, Plaisance K, Forrest A, Caplan E S. Ciprofloxacin pharmacokinetics in critically ill trauma patients. Am J Med 1989, Suppl 5A: 70S–75S
   Google Scholar
• Smith G M, Leyland M J, Farrell I D, Geddes A M. Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. J Antimicrob Chemother 1986; 18(Suppl D)165–174
   PubMedGoogle Scholar
• Karp J E, Merz W G, Hendricksen C, Laughon B, Redden T, Bamberger B J, Bartlett J G, Saral R, Burke P J. Infection management during antileukemic treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. Scand J Infect Dis 1986, Suppl 48: 66–78
   Google Scholar
• Winston D J, Ho W G, Champlin R E, Karp J, Bartlett J, Finley R S, Joshi J H, Talbot G, Levitt L, Deresinski S, Corrado M. Norfloxacin for prevention of bacterial infections in granulocytopenic patients. Am J Med 1987; 82(Suppl 6B)40–46
   PubMed Web of Science ®Google Scholar
• Dekker A W, Rozenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987; 106: 7–12
   PubMed Web of Science ®Google Scholar
• Kern W, Kurrle E. Ofloxacin versus trimethoprim-sulfametoxazole for prevention of infection in patients with acute leukemia and granulocytopenia. Infection 1991; 19: 73
   PubMed Web of Science ®Google Scholar
• Winston D J, Ho W G, Nakao S L, Gale R P, Champlin R E. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med 1986; 80: 884–890
   PubMed Web of Science ®Google Scholar
• Winston D J, Ho W G, Bruckner D A, Gale R P. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med 1990; 88: 36–42
   PubMed Web of Science ®Google Scholar